Origimm Biotechnology

ProVaDis: Protection-based Vaccine Discovery

Sanja Selak

The role of P. acnes in the pathogenesis of acne vulgaris

Acne vulgaris continues to burden every generation, and despite the multitude of the treatments and products on the market, there is still no magic formula that can guarantee a long-term benefit to all acne patients. Antibiotics are most common treatment. However they cannot be given long term. Furthermore, widespread use of antibiotics is thought to be a factor in the rise of antibiotic-resistant bacteria, possibly leading to greater harm than benefit. Vitamin A derivatives (isotretinoins) represent the second widely used… Continue reading

Vaccine industry challenges

Infectious diseases are still the leading global cause of morbidity and mortality. Vaccine-preventable diseases are still responsible for about 25% of the 10 million deaths occurring annually among children under five years of age, and ~25% of adult (15–59 years) deaths are still attributed to infectious diseases.1 Moreover, infectious diseases continue to rise due to an alarming rate of antibiotic resistance among bacteria, and due to the trends of pathogen spreading driven by globalization and enlarged mobility.

Despite the… Continue reading